SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-006294
Filing Date
2022-03-08
Accepted
2022-03-08 16:05:30
Documents
12
Period of Report
2022-03-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 33104
  Complete submission text file 0001493152-22-006294.txt   205636

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE gtbp-20220302.xsd EX-101.SCH 3042
3 XBRL LABEL FILE gtbp-20220302_lab.xml EX-101.LAB 34476
4 XBRL PRESENTATION FILE gtbp-20220302_pre.xml EX-101.PRE 22601
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3598
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40023 | Film No.: 22721714
SIC: 2834 Pharmaceutical Preparations